rxstat › Drug prices › Levomilnacipran

Levomilnacipran (Fetzima) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Levomilnacipran 20 mg capsule (extended-release) costs about $3.89 per capsule on public drug plan price lists in Alberta, before the pharmacy's dispensing fee. It is not a covered benefit on the public plans we track; the price shown is a list price.

Levomilnacipran has no current shortage reported in Canada. It has been in shortage before; the history is below.

Price by province

Strength and formAB
20 mg Capsule (Extended-Release)per capsule$3.89not covered
40 mg Capsule (Extended-Release)per capsule$4.03not covered
80 mg Capsule (Extended-Release)per capsule$4.30not covered
120 mg Capsule (Extended-Release)per capsule$4.59not covered
Plan coverageNot covered

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 4 products
  • Fetzima 20 mg Capsule (Extended-Release) · ABV
    DIN 02440970 · $3.89/capsule · Not covered
  • Fetzima 40 mg Capsule (Extended-Release) · ABV
    DIN 02440989 · $4.03/capsule · Not covered
  • Fetzima 80 mg Capsule (Extended-Release) · ABV
    DIN 02440997 · $4.30/capsule · Not covered
  • Fetzima 120 mg Capsule (Extended-Release) · ABV
    DIN 02441004 · $4.59/capsule · Not covered

Price sources: Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 3
Reports on file
3

Reports by product

The DIN is printed on your prescription label.

Resolved
FETZIMA
120MG · CAPSULE (EXTENDED RELEASE) · ABBVIE CORPORATION
DIN 02441004 · ended Aug 15, 2023 · Disruption of the manufacture of the drug.
Resolved
FETZIMA
20MG · CAPSULE (EXTENDED RELEASE) · ALLERGAN INC
DIN 02440970 · ended Jun 6, 2019 · Potential issue with the label
Resolved
FETZIMA
80MG · CAPSULE (EXTENDED RELEASE) · ALLERGAN INC
DIN 02440997 · ended Jun 6, 2019 · Potential issue with the label

What's happening

There are no active shortage reports for Levomilnacipran. Health Canada has 3 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Recent changes

Common questions

How much does Levomilnacipran cost in Canada?

Levomilnacipran 20 mg capsule (extended-release) costs about $3.89 per capsule on public drug plan price lists in Alberta, before the pharmacy's dispensing fee. It is not a covered benefit on the public plans we track; the price shown is a list price.

Is Levomilnacipran covered by provincial drug plans?

On the public plans' own lists: Alberta: not covered. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Levomilnacipran be back in stock in Canada?

Levomilnacipran has no active shortage; supply is normal per Health Canada reports.

Why is Levomilnacipran in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.